Journal article
Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: A comparative dosimetric study with early clinical outcome
International journal of radiation oncology, biology, physics, v 64(5), pp 1395-1400
01 Apr 2006
PMID: 16442238
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Objectives: To assess early clinical outcome of intensity-modulated radiation therapy (IMRT) in the treatment of vulvar cancer and compare dosimetric parameters with 3D conformal radiotherapy (3D CRT).
Methods: Fifteen patients with vulvar cancer were treated with IMRT. Seven patients were treated with preoperative chemoradiation, and 8 patients were treated with adjuvant postoperative radiation therapy. Median dose was 46 Gy in the preoperative and 50.4 Gy in the postoperative group.
Results: The mean volume of small bowel, rectum, and bladder that received doses in excess of 30 Gy with IMRT was reduced when compared with 3D CRT. Treatment was well tolerated, and only 1 patient had acute Grade 3 small-bowel toxicity. Median follow-up was 12 months. In the preoperative group, 5 patients (71%) had clinical complete response and 3 patients (42.8%) had pathologic complete response. In the adjuvant group, 2 patients had recurrences in the treatment field. No patients had late Grade 3 toxicity. The 2-year actuarial disease-specific survival was 100%.
Conclusions: Intensity-modulated RT appears to offer advantages over 3D CRT treatment of vulvar cancer by elimination of dose modulation across overlapping regions and reduction of unnecessary dose to the bladder, rectum, and small bowel. Early results with a small number of patients show promising results, with a low incidence of severe toxicity.
Metrics
Details
- Title
- Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: A comparative dosimetric study with early clinical outcome
- Creators
- Sushil Beriwal - UPMC Hillman Cancer CenterDwight E. Heron - UPMC Hillman Cancer CenterHayeon Kim - UPMC Hillman Cancer CenterGwendolyn King - UPMC Hillman Cancer CenterJeffrey Shogan - UPMC Hillman Cancer CenterSanjeev Bahri - UPMC Hillman Cancer CenterKristina Gerszten - UPMC Hillman Cancer CenterJoe Lee - Drug Development and DiscoveryJoseph Kelley - UPMC Hillman Cancer CenterRobert P. Edwards - UPMC Hillman Cancer Center
- Publication Details
- International journal of radiation oncology, biology, physics, v 64(5), pp 1395-1400
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:000236477200015
- Scopus ID
- 2-s2.0-33645337096
- Other Identifier
- 991021897390704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging